While not identified within our matched tumor sample, prior genetics work have linked CDK2NA mutations to decreased survival in anaplastic meningioma [50], and TERT promoter mutations to decreased OS in both higher grade meningioma [29] and across tumor grades [31]. This evidence concerns the gene TERT and neoplasm.